Enzychem Lifesciences Corporation (KOSDAQ: 183490)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,290.00
-36.00 (-2.71%)
Dec 20, 2024, 9:00 AM KST

Enzychem Lifesciences Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
102,990154,649139,497457,391869,255553,292
Upgrade
Market Cap Growth
-6.21%10.86%-69.50%-47.38%57.11%-27.13%
Upgrade
Enterprise Value
-7,61616,479-29,937400,389835,243517,193
Upgrade
Last Close Price
1290.001818.001655.009150.0013885.049274.26
Upgrade
PS Ratio
1.312.035.2419.9133.6717.58
Upgrade
PB Ratio
0.580.790.696.1311.997.47
Upgrade
P/TBV Ratio
0.700.820.706.7312.337.65
Upgrade
EV/Sales Ratio
0.110.22-17.4332.3516.44
Upgrade
Debt / Equity Ratio
0.030.030.190.700.590.04
Upgrade
Asset Turnover
0.400.330.140.180.250.41
Upgrade
Inventory Turnover
5.495.802.672.592.823.85
Upgrade
Quick Ratio
14.2710.634.791.879.727.29
Upgrade
Current Ratio
17.7712.335.212.0510.738.43
Upgrade
Return on Equity (ROE)
-4.16%-4.74%-18.16%-37.87%-23.90%-25.41%
Upgrade
Return on Assets (ROA)
-3.71%-4.01%-4.81%-10.10%-11.44%-13.49%
Upgrade
Return on Capital (ROIC)
-3.92%-4.19%-5.01%-10.71%-12.40%-14.66%
Upgrade
Earnings Yield
-7.36%-6.03%-17.99%-6.09%-2.01%-3.05%
Upgrade
FCF Yield
-3.80%-8.09%-15.97%-5.34%-1.94%-3.24%
Upgrade
Buyback Yield / Dilution
33.09%-7.75%-56.10%-3.93%-3.53%-3.34%
Upgrade
Total Shareholder Return
33.09%-7.75%-56.10%-3.93%-3.53%-3.34%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.